Lennart Minthon

28.7k citations

264 papers · 18.9k indexed · 4 hit papers · h-index 76

Psychiatry and Mental health top 0.05%
- Dementia and Cognitive Impairment Research 132
Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments 26
- Neurological Disease Mechanisms and Treatments 17
- Neuroinflammation and Neurodegeneration Mechanisms 16
Biological Psychiatry top 0.2%
Physiology top 0.05%
- Alzheimer's disease research and treatments 148
Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments 26
- Neurological Disease Mechanisms and Treatments 17
- Neuroinflammation and Neurodegeneration Mechanisms 16
Cognitive Neuroscience
- Functional Brain Connectivity Studies 22
Pharmacology
- Cholinesterase and Neurodegenerative Diseases 21
Molecular Biology
- Amyloidosis: Diagnosis, Treatment, Outcomes 13

Co-authors: Kaj Blennow Oskar Hansson Elisabet Londos Henrik Zetterberg Peder Buchhave Niels Andreasen Eugeen Vanmechelen Pia Davidsson
Cited by: Psychiatry and Mental health Neurology Biological Psychiatry
Journals: The Lancet (1 paper)Nature Communications (1 paper)SHILAP Revista de lepidopterología (2 papers)
Partner nations: Sweden United States United Kingdom

In The Last Decade

Lennart Minthon

260 papers receiving 18.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 Annals of Clinical and Translational Neurology
2010 Annals of Neurology
2006 The Lancet Neurology
1999 Archives of Neurology

Peers

Countries citing papers authored by Lennart Minthon

Since Specialization

Citations

This map shows the geographic impact of Lennart Minthon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lennart Minthon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lennart Minthon more than expected).

Fields of papers citing papers by Lennart Minthon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lennart Minthon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lennart Minthon. The network helps show where Lennart Minthon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lennart Minthon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lennart Minthon Line = papers co-authored together Lennart Minthon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cognitive Test Results are Associated with Mortality and Rehospitalization in Heart Failure: Swedish Prospective Cohort Study ESC Heart Failure ·Hannes Holm,Erasmus Bachus,Amra Jujić,Erik Nilsson,Benjamin Nilsson Wadström,John Molvin,Lennart Minthon,Artur Fedorowski,Katarina Nägga,Martin Magnusson	2020	44
2	REST suppression mediates neural conversion of adult human fibroblasts via microRNA‐dependent and ‐independent pathways EMBO Molecular Medicine ·Janelle Drouin‐Ouellet,Shong Lau,Per Ludvik Brattås,Daniella Rylander Ottosson,Karolina Pircs,Daniela A. Grassi,Lucy Collins,Romina Vuono,Annika Andersson Sjöland,Gunilla Westergren‐Thorsson,Caroline Graff,Lennart Minthon,Håkan Toresson,Roger A. Barker,Johan Jakobsson,Malin Parmar	2017	80
3	Importance and added value of functional impairment to predict mortality: a cohort study in Swedish medical inpatients BMJ Open ·Gustav Torisson,Lars Stavenow,Lennart Minthon,Elisabet Londos	2017	16
4	The effect of white matter hyperintensities on statistical analysis of diffusion tensor imaging in cognitively healthy elderly and prodromal Alzheimer's disease PLoS ONE ·Daniel Svärd,Markus Nilsson,Björn Lampinen,Jimmy Lätt,Pia C. Sundgren,Erik Stomrud,Lennart Minthon,Oskar Hansson,Danielle van Westen	2017	35
5	A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer’s Disease Journal of Alzheimer s Disease ·C Andersson,Oskar Hansson,Lennart Minthon,Niels Andreasen,Kaj Blennow,Henrik Zetterberg,Ingmar Skoog,Anders Wallin,Staffan Nilsson,Petronella Kettunen	2016	27
6	Risk Factors That Affect Life Expectancy in Alzheimer's Disease: A 15-Year Follow-Up Dementia and Geriatric Cognitive Disorders ·Carina Wattmo,Elisabet Londos,Lennart Minthon	2014	46
7	Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer’s Disease NeuroMolecular Medicine ·Christoffer Rosén,Ulf Andréasson,Niklas Mattsson,Jan Marcusson,Lennart Minthon,Niels Andreasen,Kaj Blennow,Henrik Zetterberg	2012	55
8	A new automated method for analysis of rCBF‐SPECT images based on the active‐shape algorithm: normal values Clinical Physiology and Functional Imaging ·Douglas Hägerström,David Jakobsson,Erik Stomrud,Ann‐Margret Andersson,Erik Ryding,Elisabet Londos,Lennart Minthon,Ingmar Rosén,Lars Edenbrandt	2011	3
9	The association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent Neurobiology of Aging ·Heidi I.L. Jacobs,Pieter Jelle Visser,Martin P.J. van Boxtel,Giovanni B. Frisoni,Magda Tsolaki,P. Papapostolou,Flavio Nobili,Lars‐Olof Wahlund,Lennart Minthon,Lutz Frölich,Harald Hampel,Hilkka Soininen,Laura van de Pol,Philip Scheltens,Frans E. S. Tan,Jelle Jolles,Frans R.J. Verhey	2010	64
10	¹⁸F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trialbreakdown → Annals of Neurology ·Rik Vandenberghe,Koen Van Laere,Adrian Ivanoiu,Éric Salmon,Christine Bastin,Eric Triau,Steen Gregers Hasselbalch,Ian Law,Allan W. Andersen,Alex Kørner,Lennart Minthon,Gaëtan Garraux,Natalie Nelissen,Guy Bormans,Christopher Buckley,Rikard Owenius,Lennart Thurfjell,Gill Farrar,David J. Brooks	2010	506
11	Cube Copying Test in Combination with rCBF or CSF Aβ<sub>42</sub>Predicts Development of Alzheimer’s Disease Dementia and Geriatric Cognitive Disorders ·Peder Buchhave,Erik Stomrud,Siegbert Warkentin,Kaj Blennow,Lennart Minthon,Oskar Hansson	2008	19
12	Electroencephalogram Variability in Dementia with Lewy Bodies, Alzheimer’s Disease and Controls Dementia and Geriatric Cognitive Disorders ·Maria Andersson,Oskar Hansson,Lennart Minthon,I. Rosén,Elisabet Londos	2008	38
13	Cerebrospinal Fluid Biomarkers Predict Decline in Subjective Cognitive Function over 3 Years in Healthy Elderly Dementia and Geriatric Cognitive Disorders ·Erik Stomrud,Oskar Hansson,Kaj Blennow,Lennart Minthon,Elisabet Londos	2007	134
14	Erratum: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study (Lancet Neurology (2006) 5 (228-34)) UCL Discovery (University College London) ·Oskar Hansson,Henrik Zetterberg,(unknown),Elisabet Londos,Kaj Blennow,Lennart Minthon	2006	0
15	Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studybreakdown → The Lancet Neurology ·Oskar Hansson,Henrik Zetterberg,Peder Buchhave,Elisabet Londos,Kaj Blennow,Lennart Minthon	2006	1261
16	Five-Year Outcome of Cholinergic Treatment of Alzheimer’s Disease: Early Response Predicts Prolonged Time until Nursing Home Placement, but Does Not Alter Life Expectancy Dementia and Geriatric Cognitive Disorders ·A. Wallin,Lars Gustafson,Magnus Sjögren,Carina Wattmo,Lennart Minthon	2004	35
17	Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients Experimental Neurology ·Annika Olsson,Kina Höglund,Magnus Sjögren,Niels Andreasen,Lennart Minthon,Lars Lannfelt,Katharina Büerger,Hans‐Jürgen Möller,Harald Hampel,Pia Davidsson,Kaj Blennow	2003	109
18	CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging Journal of Neural Transmission ·Magnus Sjögren,Lennart Minthon,Pia Davidsson,Ann‐Kathrine Granérus,A. Clarberg,Hugo Vanderstichele,Eugeen Vanmechelen,Anders Wallin,Kaj Blennow	2000	205
19	Redistribution of blood flow in the cerebral cortex of normal subjects during head-up postural change Clinical Autonomic Research ·Siegbert Warkentin,Ulla Passant,Lennart Minthon,Siv Karlson,Lars Edvinsson,R. Fäldt,Lars Gustafson,Jarl Risberg	1992	30
20	Neuropeptide levels in Alzheimer’s disease and dementia with frontotemporal degeneration PubMed ·Lennart Minthon,Lars Edvinsson,Rolf Ekman,L. Gustafson	1990	25

About Lennart Minthon

Lennart Minthon is a scholar working on Psychiatry and Mental health, Physiology and Neurology, having authored 264 papers that have together received 18.9k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (148 papers), Dementia and Cognitive Impairment Research (132 papers), Parkinson's Disease Mechanisms and Treatments (26 papers), Functional Brain Connectivity Studies (22 papers), Cholinesterase and Neurodegenerative Diseases (21 papers), Neurological Disease Mechanisms and Treatments (17 papers), Neuroinflammation and Neurodegeneration Mechanisms (16 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers). The work is most often cited by research in Psychiatry and Mental health (8.3k citations), Neurology (3.8k citations) and Biological Psychiatry (1.1k citations). Lennart Minthon has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Kaj Blennow, Oskar Hansson, Elisabet Londos, Henrik Zetterberg, Peder Buchhave, Niels Andreasen, Eugeen Vanmechelen, Pia Davidsson, Hugo Vanderstichele and Ulf Andréasson. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact